Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Debt (2023 - 2025)

AVITA Medical's Total Debt history spans 3 years, with the latest figure at $43.0 million for Q4 2025.

  • For Q4 2025, Total Debt rose 1.75% year-over-year to $43.0 million; the TTM value through Dec 2025 reached $43.0 million, up 1.75%, while the annual FY2025 figure was $43.0 million, 1.75% up from the prior year.
  • Total Debt reached $43.0 million in Q4 2025 per RCEL's latest filing, up from $42.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $45.2 million in Q2 2025 to a low of $39.8 million in Q4 2023.
  • Average Total Debt over 3 years is $42.4 million, with a median of $42.4 million recorded in 2025.
  • The largest YoY upside for Total Debt was 10.31% in 2025 against a maximum downside of 0.23% in 2025.
  • A 3-year view of Total Debt shows it stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then grew by 1.75% to $43.0 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Total Debt are $43.0 million (Q4 2025), $42.4 million (Q3 2025), and $45.2 million (Q2 2025).